ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis

類似資料

• Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment
  著者:: Clamp, A, 等
  出版事項: (2018)
• Quality of life of weekly, dose-dense versus standard chemotherapy for ovarian cancer in the ICON8 study
  著者:: Blagden, S, 等
  出版事項: (2017)
• Primary fallopian tube carcinoma
  著者:: Ben-Shian Huang, 等
  出版事項: (2012-03-01)
• Primary Fallopian Tube Carcinoma
  著者:: Prasad K Shetty, 等
  出版事項: (2011-01-01)
• Principles of emergency management and emergency operations centers (EOC) /
  著者:: Fagel, Michael J.
  出版事項: (2011)